Latest Insider Transactions at Hims & Hers Health, Inc. (HIMS)
This section provides a real-time view of insider transactions for Hims & Hers Health, Inc. (HIMS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Hims & Hers Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Hims & Hers Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 29
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-35.19%
|
$1,800,000
$36.39 P/Share
|
|
Apr 29
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+26.03%
|
$100,000
$2.43 P/Share
|
|
Apr 28
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
41,667
-31.15%
|
$1,250,010
$30.19 P/Share
|
|
Apr 28
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,667
+23.75%
|
$83,334
$2.43 P/Share
|
|
Apr 28
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,236
-1.99%
|
$97,080
$30.19 P/Share
|
|
Apr 22
2025
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
2,936
-36.67%
|
$76,336
$26.49 P/Share
|
|
Apr 21
2025
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
33,333
-2.0%
|
$833,325
$25.98 P/Share
|
|
Apr 21
2025
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,333
+1.96%
|
$66,666
$2.09 P/Share
|
|
Apr 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
47,534
-12.5%
|
$1,330,952
$28.23 P/Share
|
|
Apr 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,460
-14.57%
|
$1,020,880
$28.17 P/Share
|
|
Apr 16
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,668
+12.33%
|
$67,336
$2.43 P/Share
|
|
Apr 15
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,581
-8.87%
|
$324,268
$28.5 P/Share
|
|
Apr 15
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,437
+2.41%
|
$51,496
$8.27 P/Share
|
|
Apr 14
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,236
-1.95%
|
$90,608
$28.72 P/Share
|
|
Apr 09
2025
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
33,337
-1.01%
|
$900,099
$27.64 P/Share
|
|
Apr 09
2025
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,337
+3.82%
|
$33,337
$1.75 P/Share
|
|
Apr 04
2025
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,380
+4.78%
|
$201,900
$5.01 P/Share
|
|
Apr 03
2025
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
2,203
-21.58%
|
$61,684
$28.78 P/Share
|
|
Apr 02
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,581
-8.54%
|
$335,849
$29.26 P/Share
|
|
Apr 02
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,437
+4.53%
|
$32,185
$5.01 P/Share
|
|
Mar 31
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,236
-1.86%
|
$87,372
$27.77 P/Share
|
|
Mar 31
2025
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,460
+1.73%
|
$67,300
$5.01 P/Share
|
|
Mar 26
2025
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
67,687
-1.71%
|
$2,369,045
$35.48 P/Share
|
|
Mar 26
2025
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
67,687
+7.63%
|
$0
$0.4 P/Share
|
|
Mar 21
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
23,118
-15.17%
|
$739,776
$32.41 P/Share
|
|
Mar 18
2025
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
8,277
-44.77%
|
$281,418
$34.31 P/Share
|
|
Mar 18
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,236
-1.83%
|
$110,024
$34.31 P/Share
|
|
Mar 18
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
78,760
-25.69%
|
$2,599,080
$33.94 P/Share
|
|
Mar 18
2025
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
23,287
-10.0%
|
$791,758
$34.31 P/Share
|
|
Mar 17
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
47,534
-5.64%
|
$1,568,622
$33.85 P/Share
|
|
Mar 17
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
128,127
-10.19%
|
$4,228,191
$33.44 P/Share
|
|
Mar 17
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,335
+12.54%
|
$250,670
$2.43 P/Share
|
|
Mar 14
2025
|
Irene Becklund PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,813
-29.71%
|
$257,829
$33.14 P/Share
|
|
Mar 14
2025
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,097
+47.81%
|
-
|
|
Mar 14
2025
|
Christiane Pendarvis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,211
+36.36%
|
-
|
|
Mar 14
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,798
-11.87%
|
$785,334
$33.14 P/Share
|
|
Mar 14
2025
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
43,210
+17.73%
|
-
|
|
Mar 14
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
51,671
-25.32%
|
$1,705,143
$33.14 P/Share
|
|
Mar 14
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
93,718
+31.47%
|
-
|
|
Mar 14
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
97,551
-35.6%
|
$3,219,183
$33.14 P/Share
|
|
Mar 14
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
176,311
+39.15%
|
-
|
|
Mar 14
2025
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,162
-1.34%
|
$104,346
$33.14 P/Share
|
|
Mar 14
2025
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,275
+13.32%
|
-
|
|
Mar 14
2025
|
Melissa Baird Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
28,779
-3.69%
|
$949,707
$33.14 P/Share
|
|
Mar 14
2025
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
73,150
+8.57%
|
-
|
|
Mar 14
2025
|
Michael Chi Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
42,305
-15.66%
|
$1,396,065
$33.14 P/Share
|
|
Mar 14
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
76,508
+22.07%
|
-
|
|
Mar 11
2025
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
2,203
-50.0%
|
$74,902
$34.77 P/Share
|
|
Mar 05
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,530
+2.24%
|
$12,650
$5.01 P/Share
|
|
Mar 05
2025
|
Christiane Pendarvis Director |
SELL
Open market or private sale
|
Direct |
12,500
-52.26%
|
$500,000
$40.0 P/Share
|